Literature DB >> 22711307

Association of growth factors, HIF-1 and NF-κB expression with proteasomes in endometrial cancer.

Ludmila V Spirina1, Nataliya V Yunusova, Irina V Kondakova, Larisa A Kolomiets, Valeriya D Koval, Alena L Chernyshova, Olga V Shpileva.   

Abstract

Insulin-like growth factors (IGFs), vascular endothelial growth factor (VEGF), hypoxia-inducible factor-1 (HIF-1), and nuclear factor kappa-B (NF-κB) are known to play an important role in endometrial cancer pathogenesis. However, the proteolytic regulation of these factors is still poorly understood. We studied the correlation between chymotrypsin-like activity of proteasomes and IGF-I, IGF-II, VEGF, HIF-1, and NF-κB levels in endometrial cancer tissues. It was shown that the total activity of proteasomes and the activity of the 20S and 26S proteasomes in malignant tumors were significantly higher than those observed in the normal endometrium. Negative relationships between the proteasome activity and IGF-I, HIF-1, and NF-κB p50 expressions were found. High 20S proteasome activity was associated with increase of HIF-1 level. Positive relationships between IGF-I expression and two classic forms of NF-κB p50 and p65 in endometrial cancer were revealed. The data obtained indicate the possible proteasomal regulation of growth and transcription factors. The major pool of IGF-I is located in the extracellular space, and it is likely that extracellular proteasomes also take part in the regulation of the IGF-I content. The present data show the evidence of proteasome regulation of growth and nuclear factors that can play an important role in cancer pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22711307     DOI: 10.1007/s11033-012-1720-y

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  39 in total

Review 1.  Structure, assembly and homeostatic regulation of the 26S proteasome.

Authors:  Youming Xie
Journal:  J Mol Cell Biol       Date:  2010-10-07       Impact factor: 6.216

2.  The prognostic impact of circulating proteasome concentrations in patients with epithelial ovarian cancer.

Authors:  Martin Heubner; Pauline Wimberger; Burkhardt Dahlmann; Sabine Kasimir-Bauer; Rainer Kimmig; Jürgen Peters; Jeremias Wohlschlaeger; Stephan Urs Sixt
Journal:  Gynecol Oncol       Date:  2010-11-13       Impact factor: 5.482

Review 3.  Functions of the proteasome: from protein degradation and immune surveillance to cancer therapy.

Authors:  A L Goldberg
Journal:  Biochem Soc Trans       Date:  2007-02       Impact factor: 5.407

4.  Bortezomib induces nuclear translocation of IκBα resulting in gene-specific suppression of NF-κB--dependent transcription and induction of apoptosis in CTCL.

Authors:  Ashish Juvekar; Subrata Manna; Sitharam Ramaswami; Tzu-Pei Chang; Hai-Yen Vu; Chandra C Ghosh; Mahmut Y Celiker; Ivana Vancurova
Journal:  Mol Cancer Res       Date:  2011-01-11       Impact factor: 5.852

5.  Tumor necrosis factor alpha and phorbol 12-myristate-13-acetate down-regulate human 11beta-hydroxysteroid dehydrogenase type 2 through p50/p50 NF-kappaB homodimers and Egr-1.

Authors:  Radina M Kostadinova; Andrea R Nawrocki; Felix J Frey; Brigitte M Frey
Journal:  FASEB J       Date:  2005-01-19       Impact factor: 5.191

6.  Overexpression of the insulin-like growth factor I receptor and activation of the AKT pathway in hyperplastic endometrium.

Authors:  Adrienne S McCampbell; Russell R Broaddus; David S Loose; Peter J A Davies
Journal:  Clin Cancer Res       Date:  2006-11-01       Impact factor: 12.531

7.  Prognostic significance of VEGF and its receptors in endometrioid endometrial cancer.

Authors:  Bozena Dobrzycka; Sławomir Jerzy Terlikowski; Marcin Kwiatkowski; Magdalena Garbowicz; Maciej Kinalski; Lech Chyczewski
Journal:  Ginekol Pol       Date:  2010-06       Impact factor: 1.232

8.  Steroid-modulated proliferation of human endometrial carcinoma cell lines: any role for insulin-like growth factor signaling?

Authors:  Susanne C J P Gielen; Eline E Hanekamp; Leen J Blok; Frans J Huikeshoven; Curt W Burger
Journal:  J Soc Gynecol Investig       Date:  2005-01

9.  Proteasomal degradation of IRS-2, but not IRS-1 by calcineurin inhibition: attenuation of insulin-like growth factor-I-induced GSK-3beta and ERK pathways in adrenal chromaffin cells.

Authors:  Shinya Satoh; Toshihiko Yanagita; Toyoaki Maruta; Takayuki Nemoto; Norie Yoshikawa; Hideyuki Kobayashi; Tetsuya Tono; Akihiko Wada
Journal:  Neuropharmacology       Date:  2008-04-26       Impact factor: 5.250

10.  Mdm2-dependent ubiquitination and degradation of the insulin-like growth factor 1 receptor.

Authors:  Leonard Girnita; Ada Girnita; Olle Larsson
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-23       Impact factor: 12.779

View more
  6 in total

1.  Activating IL-6/STAT3 Enhances Protein Stability of Proteasome 20S α+β in Colorectal Cancer by miR-1254.

Authors:  Weiguo Ren; Xuexiu Zhang; Qiang Li; Chibin Pu; Decai Zhang
Journal:  Biomed Res Int       Date:  2022-05-14       Impact factor: 3.246

2.  Expression of vascular endothelial growth factor and transcription factors HIF-1, NF-kB expression in squamous cell carcinoma of head and neck; association with proteasome and calpain activities.

Authors:  Liudmila V Spirina; Irina V Kondakova; Evgeny L Choynzonov; Svetlana Y Chigevskaya; Dmitry A Shishkin; Denis Y Kulbakin
Journal:  J Cancer Res Clin Oncol       Date:  2012-12-27       Impact factor: 4.553

3.  The roles of beta-adrenergic receptors in tumorigenesis and the possible use of beta-adrenergic blockers for cancer treatment: possible genetic and cell-signaling mechanisms.

Authors:  Khanh Vinh Quốc Lu'o'ng; Lan Thi Hoàng Nguyễn
Journal:  Cancer Manag Res       Date:  2012-12-18       Impact factor: 3.989

4.  Proteasome functioning in breast cancer: connection with clinical-pathological factors.

Authors:  Elena E Shashova; Yulia V Lyupina; Svetlana A Glushchenko; Elena M Slonimskaya; Olga V Savenkova; Alexey M Kulikov; Nikolay G Gornostaev; Irina V Kondakova; Natalia P Sharova
Journal:  PLoS One       Date:  2014-10-17       Impact factor: 3.240

5.  Tumor necrosis is an important hallmark of aggressive endometrial cancer and associates with hypoxia, angiogenesis and inflammation responses.

Authors:  Geir Bredholt; Monica Mannelqvist; Ingunn M Stefansson; Even Birkeland; Trond Hellem Bø; Anne M Øyan; Jone Trovik; Karl-Henning Kalland; Inge Jonassen; Helga B Salvesen; Elisabeth Wik; Lars A Akslen
Journal:  Oncotarget       Date:  2015-11-24

Review 6.  Estrogen Receptors and Ubiquitin Proteasome System: Mutual Regulation.

Authors:  Irina V Kondakova; Elena E Shashova; Evgenia A Sidenko; Tatiana M Astakhova; Liudmila A Zakharova; Natalia P Sharova
Journal:  Biomolecules       Date:  2020-03-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.